Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background: Ketamine is a highly effective antidepressant for patients with treatment-resistant major depressive disorder (MDD). Resting-state fMRI studies show disruptions of functional connectivity (FC) between limbic regions and resting-state networks (RSNs) including default mode (DMN), central executive (CEN), and salience networks (SN) in MDD. Here, we investigated whether serial ketamine treatments change FC between limbic structures and RSNs. Methods: MDD patients (n=44) were scanned at baseline (T1), and 24 hours after the first (T2), and fourth infusion (T3) of ketamine. Healthy controls (n=50) were scanned at baseline with a subgroup (n=17) rescanned at two weeks. Limbic regions included the amygdala and hippocampus and RSNs included the DMN, CEN and SN. Results: Ketamine increased right amygdala FC to the right CEN (p=0.05), decreased amygdala FC to the left CEN (p=0.005) at T2 versus T1 (p=0.015), which then increased at T3 versus T2 (p=0.002), and decreased left amygdala FC to the SN (p=0.016). Decreased left amygdala to SN FC at T2 predicted improvements in anxiety at T3 (p=0.006). Ketamine increased right hippocampus FC to left CEN (p=0.001) and this change at T2 predicted decreased anhedonia at T3 (p=0.005). Conclusions: Ketamine modulates FC between limbic regions and RSNs implicated in MDD. Increases in FC between limbic regions and the CEN suggest ketamine may be involved in restoring top-down control of emotion processing. FC decreases between the left amygdala and SN suggest ketamine may ameliorate MDD-related dysconnectivity in these circuits. Early FC changes between limbic regions and RSNs may be predictive of clinical improvements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The minimal preprocessing pipelines for the Human Connectome Project
Glasser, M. F., Sotiropoulos, S. N., Wilson, J. A., Coalson, T. S., Fischl, B., Andersson, J. L., Xu, J., Jbabdi, S., Webster, M., Polimeni, J. R., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.127 · Cited by 5,253
Large-scale brain networks and psychopathology: a unifying triple network model
Menon, V. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.08.003 · Cited by 4,168 · cited 2×
“Resting-state functional magnetic resonance imaging (rsfMRI) provides a powerful noninvasive means to examine disruptions in functional connectivity (FC) of these networks in MDD (9 – 11), implicating several resting-state networks (RSNs) (12 – 14).”
BackgroundMethodTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“https://doi.org/10.1016/j.bpsc.2020.06.015 Numerous effective pharmacotherapies are available to treat major depressive disorder (MDD); however, less than half of patients remit within the fi rst 3 months of treatment (1), and w 30% remain unresponsive to $ 2 pharmacotherapies (2,3).”
BackgroundInfluentialLarge-scale brain networks in cognition: emerging methods and principles
Bressler, S. L., & Menon, V. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.04.004 · Cited by 2,348 · cited 1×
“…parietal cortices and dorsolateral PFC (DLPFC) comprise the central executive network (CEN), which is involved in goal-directed functions such as attention, decision making, working memory, and executive control (24,25) and has been reported to show decreased connectivity in depression (26,27).”
BackgroundKaiser, R. H., Andrews-Hanna, J. R., Wager, T. D., & Pizzagalli, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0071 · Cited by 2,281
Salience processing and insular cortical function and dysfunction
Uddin, L. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3857 · Cited by 2,083 · cited 2×
“An analysis of causal connectivity showed signi fi cantly higher effective connectivity of the amygdala to the anterior insula (a node of the SN) in MDD (41), an rsfMRI analysis demonstrated increased insula FC with the amygdala (42), and another study showed increased SN connectivity in MDD (21).”
BackgroundResultThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Neurobiology of emotion perception II: implications for major psychiatric disorders
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00171-9 · Cited by 1,736 · cited 1×
“In addition to its role in episodic memory, the hippocampus is involved in the regulation of motivation and emotion, responses to emotion, and regulation/susceptibility of stress, and the amygdala is involved in the autonomic responses to emotion, emotional memory, and emotion regulation (31 – 34).”
BackgroundLimbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585 · cited 2×
“These results are consistent with the corticolimbic dysregulation model of MDD as proposed by Mayberg (27,69,72).”
BackgroundResultThe default mode network and self-referential processes in depression
Sheline, Y. I., Barch, D. M., Price, J. L., Rundle, M. M., Vaishnavi, S. N., Snyder, A. Z., Mintun, M. A., Wang, S., Coalson, R. S., & Raichle, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812686106 · Cited by 1,480
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Sheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000446107 · Cited by 1,196
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · cited 1×
“…disrupted connectivity with the dorsal cingulate (11) and insula (41,42), increased amygdala activation to faces task that resolves after antidepressant treatment (43), and lower white matter integrity between the amygdala and regions of the CEN, SN, and DMN correlated to symptom severity (44).”
BackgroundMayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166 · cited 4×
“These results are consistent with the corticolimbic dysregulation model of MDD as proposed by Mayberg (27,69,72).”
BackgroundResultInfluentialLower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
Johnstone, T., van Reekum, C. M., Urry, H. L., Kalin, N. H., & Davidson, R. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2063-07.2007 · Cited by 1,051
Koenigs, M., & Grafman, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.004 · Cited by 956 · cited 1×
“Taken together, rsfMRI studies support the theory that MDD is associated with an imbalance between hyperactive ventral and hypoactive dorsal corticolimbic systems (28 – 30).”
BackgroundKoster, E. H. W., De Lissnyder, E., Derakshan, N., & De Raedt, R. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.08.005 · Cited by 916
A meta‐analytic study of changes in brain activation in depression
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903
Chang, L. J., Yarkoni, T., Khaw, M. W., & Sanfey, A. G. (2013) · Cerebral Cortex · doi:10.1093/cercor/bhs065 · Cited by 879
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · cited 1×
“Growing evidence also suggests that multiple ketamine treatments may lead to a more durable response (6 – 8).”
BackgroundLimbic-frontal circuitry in major depression: a path modeling metanalysis
Seminowicz, D. A., Mayberg, H. S., McIntosh, A. R., Goldapple, K., Kennedy, S., Segal, Z., & Rafi-Tari, S. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.015 · Cited by 710
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Wells, A., & Davies, M. I. (1994) · Behaviour Research and Therapy · doi:10.1016/0005-7967(94)90168-6 · Cited by 640 · cited 1×
“The Snaith-Hamilton Pleasure Scale (SHAPS) (54), Depression Anxiety Stress Scale (DASS) (55,56), behavioral inhibition system (BIS) scale (57), and a combined rumination scale (58,59) were administered at all 3 time points to evaluate the effect of ketamine on speci fi c symptoms of MDD.”
MethodA Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
Behavioral activation and inhibition systems and the severity and course of depression.
Kasch, K. L., Rottenberg, J., Arnow, B. A., & Gotlib, I. H. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.4.589 · Cited by 551 · cited 1×
“The BIS scale, a measure of inhibition and avoidance that is typically elevated in depression (76,77), did not change after ketamine treatment on average.”
BackgroundSingh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525 · cited 1×
“Previous randomized placebo-controlled trials have clearly established the superiority of ketamine over placebo in improving depression (5,7,50); therefore, we chose an open-label design to minimize patient burden and to address our goal of understanding the effects of ketamine on corticolimbic…”
The Frontoparietal Control System: A Central Role in Mental Health
Cole, M. W., Repovš, G., & Anticevic, A. (2014) · The Neuroscientist · doi:10.1177/1073858414525995 · Cited by 461 · cited 1×
“…parietal cortices and dorsolateral PFC (DLPFC) comprise the central executive network (CEN), which is involved in goal-directed functions such as attention, decision making, working memory, and executive control (24,25) and has been reported to show decreased connectivity in depression (26,27).”
BackgroundAvery, J. A., Drevets, W. C., Moseman, S. E., Bodurka, J., Barcalow, J. C., & Simmons, W. K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.027 · Cited by 442
Groenewold, N. A., Opmeer, E. M., de Jonge, P., Aleman, A., & Costafreda, S. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.015 · Cited by 417
How many different ways do patients meet the diagnostic criteria for major depressive disorder?
Zimmerman, M., Ellison, W., Young, D., Chelminski, I., & Dalrymple, K. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.09.007 · Cited by 392 · cited 1×
“This may be explained by large heterogeneity of MDD (4).”
BackgroundDichter, G. S., Gibbs, D., & Smoski, M. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.028 · Cited by 375
Joshi, S. H., Espinoza, R. T., Pirnia, T., Shi, J., Wang, Y., Ayers, B., Leaver, A., Woods, R. P., & Narr, K. L. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.029 · Cited by 320 · cited 1×
“Spe-ci fi cally, smaller hippocampal volume is reported in individuals with MDD compared with nondepressed individuals (39,40), and lower nodal centralities of the left hippocampus are related to longer duration of disease (37).”
ResultSelf-citationAcute and sustained effects of cognitive emotion regulation in major depression
Erk, S., Mikschl, A., Stier, S., Ciaramidaro, A., Gapp, V., Weber, B., & Walter, H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1856-10.2010 · Cited by 313
Ketamine Treatment and Global Brain Connectivity in Major Depression
Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., DeWilde, K. E., Wong, E., Anticevic, A., Tang, C. Y., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.186 · Cited by 300
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
Lally, N., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Roiser, J. P., & Zarate, C. A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568041 · Cited by 224
Evans, J. W., Szczepanik, J., Brutsché, N., Park, L. T., Nugent, A. C., & Zarate, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.027 · Cited by 173 · cited 3×
“This is consistent with a previous study reporting that a single infusion of ketamine reduced FC between the insula (part of the SN) and DMN, which was also decreased in patients with MDD compared with HCs (45).”
BackgroundResultClinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Guevara, S., Machado-Vieira, R., Richards, E. M., Brutsche, N. E., Nolan, N. M., & Zarate, C. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08698 · Cited by 165 · cited 1×
“This may affect their baseline FC; however, we show no correlation between baseline FC and HDRS scores, and ketamine is also most likely to be used in a population exhibiting moderate to severe depressive symptoms (5,50,80).”
BackgroundReduced global functional connectivity of the medial prefrontal cortex in major depressive disorder
Murrough, J. W., Abdallah, C. G., Anticevic, A., Collins, K. A., Geha, P., Averill, L. A., Schwartz, J., DeWilde, K. E., Averill, C., Jia‐Wei Yang, G., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23235 · Cited by 153 · cited 1×
“This is in line with previous literature implicating CEN and PFC hypoconnectivity in MDD (26,63).”
ResultCao, X., Liu, Z., Xu, C., Li, J., Gao, Q., Sun, N., Xu, Y., Ren, Y., Yang, C., & Zhang, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.002 · Cited by 118 · cited 1×
“Negative FC between the hippocampus and regions of the CEN, including the bilateral PFC and bilateral parietal lobe, have been reported in HCs (71).”
BackgroundMurrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., Wong, E., Tang, C. Y., Charney, D. S., & Iosifescu, D. V. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.10 · Cited by 109 · cited 2×
“This interpretation is consistent with previous neuroimaging studies indicating that a single infusion of ketamine can induce treat-ment effects in similar regions such as the subgenual ACC, posterior parietal cortex, hippocampus, PFC, caudate, and DMN (18,45 – 47).”
BackgroundResultShou, H., Yang, Z., Satterthwaite, T. D., Cook, P. A., Bruce, S. E., Shinohara, R. T., Rosenberg, B., & Sheline, Y. I. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.01.030 · Cited by 108 · cited 1×
“Cognitive behavioral therapy has also shown increases in CEN connectivity (65) and increases in FC between the amygdala and cognitive control network (66).”
BackgroundKetamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Ionescu, D. F., Felicione, J. M., Gosai, A., Cusin, C., Shin, P., Shapero, B. G., & Deckersbach, T. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000179 · Cited by 91
Yang, Z., Oathes, D. J., Linn, K. A., Bruce, S. E., Satterthwaite, T. D., Cook, P. A., Satchell, E. K., Shou, H., & Sheline, Y. I. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.12.006 · Cited by 83 · cited 1×
“Cognitive behavioral therapy has also shown increases in CEN connectivity (65) and increases in FC between the amygdala and cognitive control network (66).”
BackgroundGärtner, M., Aust, S., Bajbouj, M., Fan, Y., Wingenfeld, K., Otte, C., Heuser-Collier, I., Böker, H., Hättenschwiler, J., Seifritz, E., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.008 · Cited by 66
Cited by
Nogo, D., Jasrai, A. K., Kim, H., Nasri, F., Ceban, F., Lui, L. M. W., Rosenblat, J. D., Vinberg, M., Ho, R., & McIntyre, R. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06105-9 · Cited by 54
Siegel, J. S., Palanca, B. J. A., Ances, B. M., Kharasch, E. D., Schweiger, J. A., Yingling, M. D., Snyder, A. Z., Nicol, G. E., Lenze, E. J., & Farber, N. B. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05762-6 · Cited by 50
“One recent study found significant changes in FC between the limbic and cortical executive networks in response to ketamine (Vasavada et al. 2020).”
BackgroundMedeiros, G. C., Matheson, M., Demo, I., Reid, M. J., Matheson, S., Twose, C., Smith, G. S., Gould, T. D., Zarate, C. A., Barrett, F. S., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00183-9 · Cited by 49
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Demchenko, I., Tassone, V. K., Kennedy, S. H., Dunlop, K., & Bhat, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864902 · Cited by 29
“(165) 44, 50 fMRI N/A • DMN, CEN, and SN chosen to”
BackgroundAlario, A. A., & Niciu, M. J. (2021) · Chronic Stress · doi:10.1177/24705470211014210 · Cited by 26
Metadata
- Authors
- Vasavada, M. M., Loureiro, J., Kubicki, A., Sahib, A., Wade, B., Hellemann, G., Espinoza, R. T., Congdon, E., Narr, K. L., & Leaver, A. M.
- Venue
- Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 6
- Issue
- 7
- Pages
- 735-744
- ISSN
- 2451-9022 (ISSN-L)
- OpenAlex
- W3038241450
- Cited by
- 51
- References
- 46
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.